TEC: Evidence Based Therapeutics
Therapeutics Education Collaboration
Medication Mythbusters – Home of the Best Science (BS) Medicine Podcast

Episode 151: PREMIUM Aiming high and long with two studies that should impact practice

In episode 151, James and Mike start of the new year with premium information so, by law we had to put it in a PREMIUM podcast. The first study we looked at was AIM-HIGH which showed us that we might need to re-assess how we use niacin and we finally have some reasonable data that helps us figure out how long to stay on a bisphosphonate.

Show notes

1) AIM-HIGH – Niacin added to statins in patients with cardiovascular disease

N Engl J Med 2011; 365:2255-67

2) The idolatry of the surrogate 

BMJ 2011;343:d7995

3) HORIZON-Pivotal Fracture Trial – using zoledronic acid for 3 years or 6 years

J Bone Min Res 2011 DOI:10.1002/jbmr.1494

Listening to this episode is for premium podcast members only. If you already have a membership, login to your account. If you aren't yet a premium subscriber, sign up today!


Upcoming Events

Practical Evidence for Informed Practice (PEIP) – October 22-23, 2021

This will be a live-streamed course from Edmonton, AB. Registration Opens August 2021

BS Medicine Podcast

BedMed: The High Blood Pressure Study

This pragmatic trial is now recruiting in BC. Make a difference and get involved with pragmatic trials (www.pragmatictrials.ca)

PEER Tools